82 FR 12456 - Advisory Board on Radiation and Worker Health (ABRWH or Advisory Board), National Institute for Occupational Safety and Health (NIOSH)
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention Federal Register Volume 82, Issue 41 (March 3, 2017)
Centers for Disease Control and Prevention
Federal Register Volume 82, Issue 41 (March 3, 2017)
| Page Range | 12456-12457 | |
| FR Document | 2017-04101 |
[Federal Register Volume 82, Number 41 (Friday, March 3, 2017)] [Notices] [Pages 12456-12457] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2017-04101] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Advisory Board on Radiation and Worker Health (ABRWH or Advisory Board), National Institute for Occupational Safety and Health (NIOSH) In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), and pursuant to the requirements of 42 CFR 83.15(a), the Centers for Disease Control and Prevention (CDC), announces the following meeting of the aforementioned committee: Times and Dates: 8:15 a.m.-5:30 p.m., CDT, March 22, 2017 8:15 a.m.-1:00 p.m., CDT, March 23, 2017 Public Comment Time and Date: 5:30 p.m.-6:30 p.m.*, CDT, March 22, 2017 * Please note that the public comment period may end before the time indicated, following the last call for comments. Members of the public who wish to provide public comments should plan to attend the public comment session at the start time listed. Place: Embassy Suites By Hilton Chicago Naperville, 1823 Abriter Court, Naperville, Illinois 60563; Phone: 630-799-5900; Fax: 630-799- 3900. Status: Open to the public, limited only by the space available. The meeting space accommodates approximately 100 people. Audio Conference Call via FTS Conferencing. The USA toll-free, dial-in number is 1-866-659-0537 with a pass code of 9933701. Skype Meeting CONNECTION: https://webconf.cdc.gov/zab6/yzdq02pl?sl=1. Background: The Advisory Board was established under the Energy Employees Occupational Illness Compensation Program Act of 2000 to advise the President on a variety of policy and technical functions required to implement and effectively manage the new compensation program. Key functions of the Advisory Board include providing advice on the development of probability of causation guidelines which have been promulgated by the Department of Health and Human Services (HHS) as a final rule, advice on methods of dose reconstruction which have also been promulgated by HHS as a final rule, advice on the scientific validity and quality of dose estimation and reconstruction efforts being performed for purposes of the compensation program, and advice on petitions to add classes of workers to the Special Exposure Cohort (SEC). In December 2000, the President delegated responsibility for funding, staffing, and operating the Advisory Board to HHS, which subsequently delegated this authority to the CDC. NIOSH implements this responsibility for CDC. The charter was issued on August 3, 2001, renewed at appropriate intervals, rechartered on March 22, 2016 pursuant to Executive Order 13708, and will expire on September 30, 2017. Purpose: This Advisory Board is charged with (a) providing advice to the Secretary, HHS, on the development of guidelines under Executive Order 13179; (b) providing advice to the Secretary, HHS, on the scientific validity and quality of dose reconstruction efforts performed for this program; and (c) upon request by the Secretary, HHS, advising the Secretary on whether there is a class of employees at any Department of Energy facility who were exposed to radiation but for whom it is not feasible to estimate their radiation dose, and on whether there is reasonable likelihood that such radiation doses may have endangered the health of members of this class. Matters for Discussion: The agenda for the Advisory Board meeting includes: NIOSH Program Update; Department of Labor Program Update; Department of Energy Program Update; Dose Reconstruction Review Methods for Future Reviews; SEC Petitions Update; Site Profile reviews for Argonne East (Naperville, Illinois), General Steel Industries (Granite City, Illinois) and Kansas City Plant (Kansas City, Missouri); SEC petitions for: Carborundum Company (1943-1976; Niagara Falls, New York), Los Alamos National Laboratory (1996-2005; Los Alamos, New Mexico), Idaho National Laboratory (1949-1970; Scoville, Idaho), Rocky Flats Plant (1984-2005; Golden, Colorado), Savannah Rivers Site (1973- 2007; Aiken, South Carolina); and Board Work Sessions. The agenda is subject to change as priorities dictate. In the event an individual cannot attend, written comments may be submitted to the contact person below well in advance of the meeting. Any written comments received will be provided at the meeting in accordance with the redaction policy provided below. Policy on Redaction of Board Meeting Transcripts (Public Comment): (1) If a person making a comment gives his or her personal information, no attempt will be made to redact the name; however, NIOSH will redact other personally identifiable information, such as contact information, social security numbers, case numbers, etc., of the commenter. (2) If an individual in making a statement reveals personal information (e.g., medical or employment information) about themselves that information will not usually be redacted. The NIOSH Freedom of Information Act (FOIA) coordinator will, however, review such revelations in accordance with the Federal Advisory Committee Act and if deemed appropriate, will redact such information. (3) If a commenter reveals personal information concerning a living third party, that information will be reviewed by the NIOSH FOIA coordinator, and upon determination, if deemed appropriated, such information will be redacted, unless the disclosure is made by the third party's authorized representative under the Energy Employees Occupational Illness Compensation Program Act (EEOICPA) program. (4) In general, information concerning a deceased third party may be disclosed; however, such information will be redacted if (a) the disclosure is made by an individual other than the survivor claimant, a parent, spouse, or child, or the authorized representative of the deceased third party; (b) if it is unclear whether the third party is living or deceased; or (c) the information is unrelated or irrelevant to the purpose of the disclosure. The Board will take reasonable steps to ensure that individuals making public comment are aware of the fact that their comments (including their name, if provided) will appear in a transcript of the meeting posted on a public Web site. Such reasonable steps include: (a) A statement read at the start of each public comment period stating that transcripts will be posted and names of speakers will not be redacted; (b) A printed copy of the statement mentioned in (a) above will be displayed on the table where individuals sign up to make public comments; (c) A statement such as outlined in (a) above will also appear with the agenda for a Board Meeting when it is posted on the NIOSH Web site; (d) A statement such as in (a) above will appear in the Federal Register [[Page 12457]] Notice that announces Board and Subcommittee meetings. Contact Person for More Information: Theodore Katz, Designated Federal Officer, NIOSH, CDC, 1600 Clifton Road NE., MS E-20, Atlanta, Georgia 30329, telephone: (513) 533-6800, toll free: 1-800-CDC-INFO, email: [email protected]. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register Notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2017-04101 Filed 3-2-17; 8:45 am] BILLING CODE 4163-18-P
![12456 Federal Register / Vol. 82, No. 41 / Friday, March 3, 2017 / Notices
the Agency for Toxic Substances and which have been promulgated by the provided at the meeting in accordance
Disease Registry. Department of Health and Human with the redaction policy provided
Services (HHS) as a final rule, advice on below.
Elaine L. Baker, Policy on Redaction of Board Meeting
methods of dose reconstruction which
Director, Management Analysis and Services have also been promulgated by HHS as Transcripts (Public Comment):
Office, Centers for Disease Control and (1) If a person making a comment
a final rule, advice on the scientific
Prevention. gives his or her personal information, no
validity and quality of dose estimation
[FR Doc. 2017–04104 Filed 3–2–17; 8:45 am] attempt will be made to redact the
and reconstruction efforts being
BILLING CODE 4163–18–P
performed for purposes of the name; however, NIOSH will redact
compensation program, and advice on other personally identifiable
petitions to add classes of workers to the information, such as contact
DEPARTMENT OF HEALTH AND information, social security numbers,
Special Exposure Cohort (SEC).
HUMAN SERVICES In December 2000, the President case numbers, etc., of the commenter.
delegated responsibility for funding, (2) If an individual in making a
Centers for Disease Control and statement reveals personal information
Prevention staffing, and operating the Advisory
Board to HHS, which subsequently (e.g., medical or employment
Advisory Board on Radiation and delegated this authority to the CDC. information) about themselves that
Worker Health (ABRWH or Advisory NIOSH implements this responsibility information will not usually be
Board), National Institute for for CDC. The charter was issued on redacted. The NIOSH Freedom of
Occupational Safety and Health August 3, 2001, renewed at appropriate Information Act (FOIA) coordinator
(NIOSH) intervals, rechartered on March 22, 2016 will, however, review such revelations
pursuant to Executive Order 13708, and in accordance with the Federal
In accordance with section 10(a)(2) of will expire on September 30, 2017. Advisory Committee Act and if deemed
the Federal Advisory Committee Act Purpose: This Advisory Board is appropriate, will redact such
(Pub. L. 92–463), and pursuant to the charged with (a) providing advice to the information.
requirements of 42 CFR 83.15(a), the Secretary, HHS, on the development of (3) If a commenter reveals personal
Centers for Disease Control and guidelines under Executive Order information concerning a living third
Prevention (CDC), announces the 13179; (b) providing advice to the party, that information will be reviewed
following meeting of the Secretary, HHS, on the scientific by the NIOSH FOIA coordinator, and
aforementioned committee: validity and quality of dose upon determination, if deemed
Times and Dates: reconstruction efforts performed for this appropriated, such information will be
8:15 a.m.–5:30 p.m., CDT, March 22, program; and (c) upon request by the redacted, unless the disclosure is made
2017 Secretary, HHS, advising the Secretary by the third party’s authorized
8:15 a.m.–1:00 p.m., CDT, March 23, on whether there is a class of employees representative under the Energy
2017 at any Department of Energy facility Employees Occupational Illness
Public Comment Time and Date: who were exposed to radiation but for Compensation Program Act (EEOICPA)
5:30 p.m.–6:30 p.m.*, CDT, March 22, whom it is not feasible to estimate their program.
2017 radiation dose, and on whether there is (4) In general, information concerning
* Please note that the public comment reasonable likelihood that such a deceased third party may be disclosed;
period may end before the time radiation doses may have endangered however, such information will be
indicated, following the last call for the health of members of this class. redacted if (a) the disclosure is made by
comments. Members of the public who Matters for Discussion: The agenda for an individual other than the survivor
wish to provide public comments the Advisory Board meeting includes: claimant, a parent, spouse, or child, or
should plan to attend the public NIOSH Program Update; Department of the authorized representative of the
comment session at the start time listed. Labor Program Update; Department of deceased third party; (b) if it is unclear
Place: Embassy Suites By Hilton Energy Program Update; Dose whether the third party is living or
Chicago Naperville, 1823 Abriter Court, Reconstruction Review Methods for deceased; or (c) the information is
Naperville, Illinois 60563; Phone: 630– Future Reviews; SEC Petitions Update; unrelated or irrelevant to the purpose of
799–5900; Fax: 630–799–3900. Site Profile reviews for Argonne East the disclosure. The Board will take
Status: Open to the public, limited (Naperville, Illinois), General Steel reasonable steps to ensure that
only by the space available. The meeting Industries (Granite City, Illinois) and individuals making public comment are
space accommodates approximately 100 Kansas City Plant (Kansas City, aware of the fact that their comments
people. Audio Conference Call via FTS Missouri); SEC petitions for: (including their name, if provided) will
Conferencing. The USA toll-free, dial-in Carborundum Company (1943–1976; appear in a transcript of the meeting
number is 1–866–659–0537 with a pass Niagara Falls, New York), Los Alamos posted on a public Web site. Such
code of 9933701. Skype Meeting National Laboratory (1996–2005; Los reasonable steps include: (a) A
CONNECTION: https:// Alamos, New Mexico), Idaho National statement read at the start of each public
webconf.cdc.gov/zab6/yzdq02pl?sl=1. Laboratory (1949–1970; Scoville, Idaho), comment period stating that transcripts
Background: The Advisory Board was Rocky Flats Plant (1984–2005; Golden, will be posted and names of speakers
established under the Energy Employees Colorado), Savannah Rivers Site (1973– will not be redacted; (b) A printed copy
Occupational Illness Compensation 2007; Aiken, South Carolina); and Board of the statement mentioned in (a) above
Program Act of 2000 to advise the will be displayed on the table where
mstockstill on DSK3G9T082PROD with NOTICES
Work Sessions.
President on a variety of policy and The agenda is subject to change as individuals sign up to make public
technical functions required to priorities dictate. comments; (c) A statement such as
implement and effectively manage the In the event an individual cannot outlined in (a) above will also appear
new compensation program. Key attend, written comments may be with the agenda for a Board Meeting
functions of the Advisory Board include submitted to the contact person below when it is posted on the NIOSH Web
providing advice on the development of well in advance of the meeting. Any site; (d) A statement such as in (a) above
probability of causation guidelines written comments received will be will appear in the Federal Register
VerDate Sep<11>2014 16:42 Mar 02, 2017 Jkt 241001 PO 00000 Frm 00030 Fmt 4703 Sfmt 4703 E:\FR\FM\03MRN1.SGM 03MRN1](https://thefederalregister.org/doc/82_FR_12497/page/1.svg)
![Federal Register / Vol. 82, No. 41 / Friday, March 3, 2017 / Notices 12457
Notice that announces Board and AdvisoryCommittees/ • Confidential Submissions—To
Subcommittee meetings. AboutAdvisoryCommittees/ submit a comment with confidential
Contact Person for More Information: ucm408555.htm. You may submit information that you do not wish to be
Theodore Katz, Designated Federal comments as follows: made publicly available, submit your
Officer, NIOSH, CDC, 1600 Clifton Road comments only as a written/paper
Electronic Submissions
NE., MS E–20, Atlanta, Georgia 30329, submission. You should submit two
telephone: (513) 533–6800, toll free: 1– Submit electronic comments in the copies total. One copy will include the
800–CDC–INFO, email: dcas@cdc.gov. following way: information you claim to be confidential
The Director, Management Analysis • Federal eRulemaking Portal: with a heading or cover note that states
and Services Office, has been delegated https://www.regulations.gov. Follow the ‘‘THIS DOCUMENT CONTAINS
the authority to sign Federal Register instructions for submitting comments. CONFIDENTIAL INFORMATION.’’ The
Notices pertaining to announcements of Comments submitted electronically, Agency will review this copy, including
meetings and other committee including attachments, to https:// the claimed confidential information, in
management activities, for both the www.regulations.gov will be posted to its consideration of comments. The
Centers for Disease Control and the docket unchanged. Because your second copy, which will have the
Prevention and the Agency for Toxic comment will be made public, you are claimed confidential information
Substances and Disease Registry. solely responsible for ensuring that your redacted/blacked out, will be available
comment does not include any for public viewing and posted on
Elaine L. Baker, confidential information that you or a https://www.regulations.gov. Submit
Director, Management Analysis and Services third party may not wish to be posted, both copies to the Division of Dockets
Office, Centers for Disease Control and such as medical information, your or
Prevention. Management. If you do not wish your
anyone else’s Social Security number, or name and contact information to be
[FR Doc. 2017–04101 Filed 3–2–17; 8:45 am] confidential business information, such made publicly available, you can
BILLING CODE 4163–18–P as a manufacturing process. Please note provide this information on the cover
that if you include your name, contact sheet and not in the body of your
information, or other information that comments and you must identify this
DEPARTMENT OF HEALTH AND identifies you in the body of your
HUMAN SERVICES information as ‘‘confidential.’’ Any
comments, that information will be information marked as ‘‘confidential’’
posted on https://www.regulations.gov. will not be disclosed except in
Food and Drug Administration
• If you want to submit a comment accordance with 21 CFR 10.20 and other
[Docket No. FDA–2017–N–0965] with confidential information that you applicable disclosure law. For more
do not wish to be made available to the information about FDA’s posting of
Joint Meeting of the Nonprescription public, submit the comment as a
Drugs Advisory Committee and the comments to public dockets, see 80 FR
written/paper submission and in the 56469, September 18, 2015, or access
Drug Safety and Risk Management manner detailed (see ‘‘Written/Paper
Advisory Committee; Notice of the information at: https://www.gpo.gov/
Submissions’’ and ‘‘Instructions’’). fdsys/pkg/FR-2015-09-18/pdf/2015-
Meeting; Establishment of a Public
Docket; Request for Comments Written/Paper Submissions 23389.pdf.
Submit written/paper submissions as Docket: For access to the docket to
AGENCY: Food and Drug Administration, read background documents or the
follows:
HHS. • Mail/Hand delivery/Courier (for electronic and written/paper comments
ACTION: Notice; establishment of a written/paper submissions): Division of received, go to https://
public docket; request for comments. Dockets Management (HFA–305), Food www.regulations.gov and insert the
and Drug Administration, 5630 Fishers docket number, found in brackets in the
SUMMARY: The Food and Drug heading of this document, into the
Lane, Rm. 1061, Rockville, MD 20852.
Administration (FDA) announces a • For written/paper comments ‘‘Search’’ box and follow the prompts
forthcoming public advisory committee submitted to the Division of Dockets and/or go to the Division of Dockets
meeting of the Nonprescription Drugs Management, FDA will post your Management, 5630 Fishers Lane, Rm.
Advisory Committee and the Drug comment, as well as any attachments, 1061, Rockville, MD 20852.
Safety and Risk Management Advisory except for information submitted, FOR FURTHER INFORMATION CONTACT:
Committee. The general function of the marked and identified, as confidential, Moon Hee V. Choi, Center for Drug
committees is to provide advice and if submitted as detailed in Evaluation and Research, Food and
recommendations to the Agency on ‘‘Instructions.’’ Drug Administration, 10903 New
FDA’s regulatory issues. The meeting Instructions: All submissions received Hampshire Ave., Bldg. 31, rm. 2417,
will be open to the public. FDA is must include the Docket No. FDA– Silver Spring, MD 20993–0002, 301–
establishing a docket for public 2017–N–0965 for ‘‘Joint Meeting of the 796–9001, FAX: 301–847–8533, email:
comment on this document. Nonprescription Drugs Advisory NDAC@fda.hhs.gov, or FDA Advisory
DATES: The meeting will be held on Committee and the Drug Safety and Risk Committee Information Line, 1–800–
April 4, 2017, from 8 a.m. to 5 p.m. Management Advisory Committee; 741–8138 (301–443–0572 in the
ADDRESSES: Tommy Douglas Conference Notice of Meeting; Establishment of a Washington, DC area). A notice in the
Center, the Ballroom, 10000 New Public Docket; Request for Comments.’’ Federal Register about last minute
Hampshire Ave., Silver Spring, MD Received comments will be placed in modifications that impact a previously
mstockstill on DSK3G9T082PROD with NOTICES
20903. The conference center’s the docket and, except for those announced advisory committee meeting
telephone number is 240–645–4000. submitted as ‘‘Confidential cannot always be published quickly
Answers to commonly asked questions Submissions,’’ publicly viewable at enough to provide timely notice.
including information regarding special https://www.regulations.gov or at the Therefore, you should always check the
accommodations due to a disability, Division of Dockets Management Agency’s Web site at http://
visitor parking, and transportation may between 9 a.m. and 4 p.m., Monday www.fda.gov/AdvisoryCommittees/
be accessed at: http://www.fda.gov/ through Friday. default.htm and scroll down to the
VerDate Sep<11>2014 16:42 Mar 02, 2017 Jkt 241001 PO 00000 Frm 00031 Fmt 4703 Sfmt 4703 E:\FR\FM\03MRN1.SGM 03MRN1](https://thefederalregister.org/doc/82_FR_12497/page/2.svg)
Document Created: 2018-02-01 14:45:56
Document Modified: 2018-02-01 14:45:56
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| FR Citation | 82 FR 12456 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR